Andrew Cope, MD, PhD

King's College London
London, United Kingdom

Head, Centre for Rheumatic Diseases, King's College London

Presentation(s):

• 0835: Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept (APIPPRA) Trial

  Sunday, November 12, 2023
  4:00 PM – 4:10 PM PT

  Disclosure information not submitted.